The possible factors affecting microglial activation in cases of obesity with cognitive dysfunction

Titikorn Chunchai1,2, Nipon Chattipakorn1,2, Siriporn C Chattipakorn3,4

  • 1Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200, Thailand.

Metabolic Brain Disease
|November 23, 2017
PubMed

Insights

Obesity is linked to cognitive decline, with microglia playing a key role. This review explores how obesity affects microglial function and brain health, seeking to clarify the underlying mechanisms.

Area of Science:

  • Neuroscience
  • Immunology
  • Metabolism

Background:

  • Obesity is a global epidemic with growing evidence linking it to cognitive decline.
  • Microglia, the brain's immune cells, are increasingly implicated in obesity-related cognitive impairment, Alzheimer's disease, and aging.
  • The precise mechanisms connecting obesity-induced microglial changes to cognitive dysfunction remain unclear.

Purpose of the Study:

  • To review current evidence on the association between altered microglial activity and cognitive function in obese models.
  • To summarize metabolite profiles, dietary, and hormonal influences on microglial activation in obesity.
  • To discuss the potential roles of microglial activation in cognitive dysfunction, including controversial findings.

Main Methods:

  • Comprehensive literature review of in vitro and in vivo studies.
  • Analysis of metabolite profiles related to obesity, adiposity, diet, and hormones.
  • Examination of microglial activation and function in various obese models.

Main Results:

  • Obesity significantly alters microglial activation and function.
  • Metabolite profiles, diet, and hormones are key factors influencing these changes.
  • Evidence suggests a strong link between obesity-induced microglial alterations and cognitive decline.

Conclusions:

  • Microglial dysfunction is a critical factor in obesity-related cognitive decline.
  • Understanding these mechanisms is crucial for developing therapeutic strategies.
  • Further research is needed to fully elucidate the complex interplay between obesity, microglia, and cognition.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
197
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
514